G49108TO
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT1 | UDP-Gal |
|
R |
|
R | |
| B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B3GALT5 | UDP-Gal |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-thio-p-Nitrophenyl |
|
[beta]-1-thio-p-Nitrophenyl | |
| B4GALT3 | UDP-Gal |
|
4-Me-lumbelyl-[beta] |
|
4-Me-lumbelyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl | |
| B4GALT1 | UDP-Gal |
|
|
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| O75367 | Core histone macro-H2A.1 | ||
| O75369 | Filamin-B | ||
| O75376 | Nuclear receptor corepressor 1 | ||
| O75385 | Serine/threonine-protein kinase ULK1 | ||
| O75391 | Sperm-associated antigen 7 | ||
| O75394 | Large ribosomal subunit protein bL33m | ||
| O75396 | Vesicle-trafficking protein SEC22b | ||
| O75400 | Pre-mRNA-processing factor 40 homolog A | ||
| O75417 | DNA polymerase theta | ||
| O75420 | GRB10-interacting GYF protein 1 |
| Pathway Name | Organism |
|---|---|
| E.coli O4-H5 | Escherichia coli |
| E.coli O4-K52 | Escherichia coli |
| E.coli O40 | Escherichia coli |
| E.coli O41 | Escherichia coli |
| E.coli O42 | Escherichia coli |
| E.coli O45rel | Escherichia coli |
| E.coli O48 | Escherichia coli |
| E.coli O53 | Escherichia coli |
| E.coli O55 | Escherichia coli |
| E.coli O56 | Escherichia coli |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 37858678 | O-GlcNAc has crosstalk with ADP-ribosylation via PARG | Li J | 2023 Nov |
|
| 37683586 | Icaritin inhibits endometrial carcinoma cells by suppressing O-GlcNAcylation of FOXC1 | Wang Y | 2023 Nov |
|
| 37945829 | O-GlcNAcylation determines the translational regulation and phase separation of YTHDF proteins | Chen Y | 2023 Nov |
|
| 37639774 | H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase | Ravindran Menon D | 2023 Nov |
|
| 37855638 | Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19 | Ye G | 2023 Nov 30 |
|
| 38007588 | O-GlcNAcylation is essential for therapeutic mitochondrial transplantation | Park JH | 2023 Nov 25 |
|
| 37993467 | Orthosteric and allosteric modulation of human HCAR2 signaling complex | Mao C | 2023 Nov 22 |
|
| 37972591 | Structural basis for human Cav1.2 inhibition by multiple drugs and the neurotoxin calciseptine | Gao S | 2023 Nov 22 |
|
| 37986614 | The O-GlcNAc dichotomy: when does adaptation become pathological? | Costa TJ | 2023 Nov 21 |
|
| 37988652 | Imidazolone as an Amide Bioisostere in the Development of β-1,3-N-Acetylglucosaminyltransferase 2 (B3GNT2) Inhibitors | Jackson JJ | 2023 Nov 21 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025